413 unknown, 220 completed, 41 recruiting, 38 withdrawn. 302 Not applicable, 80 Phase 2, 61 Phase 4, 41 Phase 1, 38 Phase 3.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LLM-Generated Medical Summaries During Hospitalization to Improve Patient Activation in High-Risk Pregnancies LLM-Generated Medical Summaries - High-risk Pregnancy, Hospitalization | Not applicable | Not yet recruiting | Sheba Medical Center | 200 | 2026-10-01 | 2026-09-16 |
| Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes Tele-diabetes Remote System - Diabetes Mellitus, Type 1 Diabetes, Mobile Health Platform | Not applicable | Recruiting | Sheba Medical Center | 100 | 2026-08-25 | 2026-09-18 |
| The Study Examines the Efficacy of Treating Limb Scars Using a Combined Pressure Garment and Silicone Sheet Compared to Treatment With a Pressure Garment Alone. The Study Aims to Develop a Comprehensive Scar Assessment Framework, Integrating Objective and Subjective Tools to Evaluate Treatment Pressure Garment and Silicone Sheet Therapy, Pressure Garment Therapy - Scars, Scars Formation | Not applicable | Not yet recruiting | Sheba Medical Center | 60 | 2026-08-15 | 2026-08-04 |
| 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients 9-cis beta-Carotene-rich extract of Dunaliella alga, Placebo Corn Oil - Retinitis Pigmentosa | Phase 1 / Phase 2 | Enrolling by invitation | Sheba Medical Center | 41 | 2026-07-26 | 2026-07-27 |
| IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel Syndrome Modified Crohn's Disease Exclusion Diet (CDED), Low FODMAP Diet - Irritable Bowel Syndrome (IBS) | Not applicable | Not yet recruiting | Ariel University | 150 | 2026-07-07 | 2026-07-16 |
| A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies SHB-02-CD19 (anti CD19 CAR-T cells) - B Cell Malignancies, Acute Lymphobkastic Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Sheba Medical Center | 50 | 2026-06-01 | 2026-03-31 |
| Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage Carbetocin, Oxytocin - Postpartum Hemorrhage, Twin Pregnancy | Phase 4 | Recruiting | Sheba Medical Center | 120 | 2026-05-05 | 2026-05-08 |
| Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch Non-invasive facial nerve monitoring patch - Parotid Gland Tumor, Facial and Neck Rhytides | Not applicable | Not yet recruiting | Sheba Medical Center | 20 | 2026-05-01 | 2026-04-13 |
| Arm Position and Blood Pressure Measurement Accuracy During Pregnancy Arm Supported at Heart Level, Arm Supported on Lap, Arm Unsupported at Side - Pregnancy, Blood Pressure Measurement in Pregnancy | Not applicable | Recruiting | Sheba Medical Center | 300 | 2026-04-12 | 2026-04-16 |
| Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury Virtual Reality pupillometry test - Traumatic Brain Injury (TBI) Patients, Healthy Participants | Recruiting | Sheba Medical Center | 150 | 2026-04-01 | 2026-04-02 | |
| The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa Alga Dunaliella Bardawil powder, Placebo:Starch - Retinitis Pigmentosa | Phase 1 / Phase 2 | Not yet recruiting | Sheba Medical Center | 30 | 2026-03-01 | 2025-10-06 |
| Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD). Data recollection - Metabolic Dysfunction-Associated Steatotic Liver Disease | Not yet recruiting | Hospital Universitari Vall d'Hebron Research Institute | 7720 | 2026-02-23 | 2026-02-24 | |
| Mitochondrial Function After Ketamine S (+) Ketamine - Major Depressive Disorder | Not yet recruiting | Sheba Medical Center | 30 | 2026-02-01 | 2026-02-10 | |
| A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies CD22 CAR-T cells - B Cell Malignancies | Phase 1 / Phase 2 | Recruiting | Sheba Medical Center | 50 | 2026-02-01 | 2026-01-16 |
| Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease Teprotumumab Injection [Tepezza] - Thyroid Eye Disease, Thyroid Eye Disease, TED | Phase 4 | Not yet recruiting | Sheba Medical Center | 40 | 2026-01-01 | 2025-12-30 |
| Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events MDMA HCl - PTSD | Phase 2 | Recruiting | Sheba Medical Center | 168 | 2025-12-24 | 2026-03-13 |
| Telemedicine-Based Emergency Physician Assessment Prior to ED Entry: A Randomized Controlled Trial Telemedicine-Based Remote Physician Assessment - Emergency Care, Telemedicine | Not applicable | Completed | Sheba Medical Center | 200 | 2025-11-18 | 2026-05-07 |
| ELITE: Deep Profiling and Algorithmic Polytherapy to Map Individual Response in Healthy Aging AgeBiotics AB-01, AgeBiotics AB-02, Metformin - Healthy Aging | Phase 2 | Completed | Sheba Medical Center | 31 | 2025-11-17 | 2026-10-13 |
| MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC Treatment De-Escalation and Early Surgery - TNBC, Triple Negative Breast Cancer, Early Breast Cancer | Phase 2 | Recruiting | Tel-Aviv Sourasky Medical Center | 54 | 2025-11-11 | 2026-01-08 |
| A Multicentric European Study to Promote Clinical Trial Readiness for STXBP1-related Disorders STXBP1 Encephalopathy With Epilepsy | Recruiting | European STXBP1 Consortium | 120 | 2025-11-04 | 2026-02-06 |
Showing 20 of 771. Sign in to see all of them.
Schizophrenia (19) · Diabetes Mellitus (16) · Stress Disorders, Post-Traumatic (16) · Pain (14) · Breast Neoplasms (13) · Multiple Sclerosis (13) · Parkinson Disease (13) · Stroke (13) · Depressive Disorder, Major (12) · Diabetes Mellitus, Type 1 (12) · Coronary Artery Disease (11) · Heart Failure (11) · Premature Birth (11) · Brain Injuries (10) · COVID-19 (10)
Blood Specimen Collection (6) · Escitalopram (6) · Exercise (5) · Magnetic Resonance Imaging (5) · Oxytocin (5) · Etodolac (4) · Ipilimumab (4) · Metformin (4) · Methylphenidate (4) · Nivolumab (4) · Propranolol (4) · Radiation (4) · Surveys and Questionnaires (4) · Therapeutics (4) · Aspirin (3)
Israel (644) · United States (12) · Germany (8) · Belgium (6) · Italy (5) · Romania (4) · Netherlands (3) · Spain (3) · Canada (2) · China (2) · France (2) · Greece (2) · Hungary (2) · Norway (2) · Poland (2)
Joseph Zohar, MD (21) · Arnon Nagler, MD (10) · Ofir Frenkel, M.D (10) · Revital Amiaz, MD (7) · Lidia Gabis, MD (6) · Mark Weiser, MD (6) · Anat Achiron, MD, PhD (5) · Itzhak Siev-Ner, MD (5) · Jacob Kuint, MD (5) · Michael Shechter, MD, MA (5) · Shlomi Matetzky, MD (5) · Aya Mohr Sasson, M.D (4) · Haggai Schermann, M.D (4) · Haim Berkenstadt, MD (4) · Michael Glikson, MD (4)
PMID 19565535, PMID 42088573, PMID 24373597, PMID 26409016, PMID 32573764, PMID 33990415, PMID 35141873, PMID 38767196, PMID 21858885, PMID 22399223, PMID 27393285, PMID 31838969, PMID 36513665, PMID 37302449, PMID 10522638, PMID 10811917, PMID 11054091, PMID 11099990, PMID 11270698, PMID 11292044, PMID 11464580, PMID 11747385, PMID 12205254, PMID 12418561, PMID 12449258, PMID 12608674, PMID 12768890, PMID 14607585, PMID 14667994, PMID 15157788, PMID 15549175, PMID 15828876, PMID 15837071, PMID 15966542, PMID 1636856, PMID 16525844, PMID 16540422, PMID 16556782, PMID 16595231, PMID 16980242, PMID 17138963, PMID 17674028, PMID 17870045, PMID 17936958, PMID 1794918, PMID 17976187, PMID 1797798, PMID 18074410, PMID 18249377, PMID 18254113